Overview

A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-10
Target enrollment:
Participant gender:
Summary
This study will be conducted to compare the efficacy, safety and patient-reported outcome of GZR4 and Insulin Icodec with or without Non-Insulin Antidiabetic Agents in subjects with Type 2 Diabetes Mellitus (T2DM) treated with basal insulin.
Phase:
PHASE3
Details
Lead Sponsor:
Gan & Lee Pharmaceuticals.